News
Correction | Novavax and Our Partner Serum Institute of India Have Completed Submission ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'Correction | Novavax and our partner Serum Institute of India have completed submission for Emergency Use Authorization of our protein-based COVID-19* vaccine to the South African drug regulator: Novavax'
Correction | Novavax and our partner Serum Institute of India have completed submission for Emergency Use Authorization (EUA) of our protein-based COVID-19* vaccine to the South African drug regulator: Novavax— ANI (@ANI) January 10, 2022
(The above story first appeared on LatestLY on Jan 11, 2022 12:22 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
